Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap22.01B
Enterprise Value23.06B
P/E Ratio7.62
PEG Ratio0.16
Price/Sales Ratio9.98
Price/Book Ratio0.67
Enterprise/Revenue10.48
Enterprise/EBITDA95.52

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin1.23
Operating Margin0.77
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.09

Income Statement

Revenue2.34B
Revenue/Share1.98
Gross Profit1.06B
EBITDA25.92M
Net Income2.4B
Diluted EPS2.12

Balance Sheet

Total Cash2.9B
Total Cash/Share2.57
Total Debt2.25B
Total Debt/Equity0.07
Current Ratio2.38
Book Value Per Share28.13

Price History

52-Week Change14.26
52-Week High22.08
52-Week Low16.13
Moving Average 50 Days17.9
Moving Average 200 Days19.1

Statistics

Average Volume13.13M
Shares Outstanding1.2B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield2.69
Payout Ratio0.24
Last Split Factor13:10
Last Split DateJune 19, 2017
AD